REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,846.00
Bid: 1,832.00
Ask: 1,834.00
Change: 43.00 (2.38%)
Spread: 2.00 (0.109%)
Open: 1,819.00
High: 1,846.00
Low: 1,809.00
Prev. Close: 1,803.00
IMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

30 Jan 2024 11:02

RNS Number : 3843B
IMI PLC
30 January 2024
 

30 January 2024

IMI plc

Future Board change

Jamie Pike to succeed Lord Smith of Kelvin as Chair

IMI plc (the "Company" or "IMI") today announces that Jamie Pike will be appointed as Chair of the IMI Board and the Nomination Committee with effect from 1 January 2025 following a comprehensive selection process and as part of its orderly succession planning activities. Lord Smith of Kelvin will seek re-election at the 2024 Annual General Meeting to facilitate a smooth transition and will step down from the Board on 31 December 2024. Lord Smith joined the Board in 2015.

Jamie joined Burmah Castrol in 1991 and was Chief Executive of Burmah Castrol Chemicals before leading the buy-out of Foseco in 2001 and its subsequent flotation in 2005. Prior to joining Burmah, he was a partner at Bain & Company. Jamie was educated at Oxford, holds an MBA from INSEAD and is a Member of the Institute of Mechanical Engineers. He has previously held roles as Chair of Cobham plc and RPC Group plc. Jamie currently holds the positions of Chair of Spirax-Sarco Engineering plc and Chair of XP Power Limited. As previously announced by Spirax-Sarco Engineering plc, Jamie will be standing down from that position during 2024 following the expiry of his nine years as a director.

Roy Twite, Chief Executive Officer said: "We are delighted that Jamie is joining the Board and taking on the role of Chair next year. He brings a wealth of listed board experience and a deep understanding of engineering. I am very much looking forward to working with him.

I would also like to take this early opportunity to thank Lord Smith of Kelvin. He has been an outstanding Chair and IMI has benefited tremendously from his guidance and support over the last nine years."

Lord Smith of Kelvin, Chair said: "It has been a privilege to work with so many talented colleagues at IMI for the last nine years and to see the Group make significant progress in this time. I am confident that IMI will be in good hands with Jamie as my successor."

Jamie Pike, incoming Chair, commented: "I am excited to be joining the team at IMI. The Company has a clear strategy rooted in its purpose of breakthrough engineering for a better world. Under Roy's leadership, the business has been transformed and I am looking forward to working with the Board and wider team to continue creating value for all of IMI's stakeholders. "

This announcement has been made in accordance with the requirements of Listing Rule 9.6.11. There is no further information to be disclosed under Listing Rule 9.6.13.

Enquiries

Louise Waldek Company Secretary Tel: 0121 717 3700

Luke Grant Head of Investor Relations Tel: +44 (0)7866 148 374

Matt Denham Headland Tel: +44 (0)7551 825 496

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFBLFXZFLBBBF
Date   Source Headline
17th Jul 20209:36 amRNSDirector/PDMR Shareholding - Replacement
15th Jul 20202:32 pmRNSDirector/PDMR Shareholding
2nd Jul 202011:37 amRNSBlock listing Interim Review
1st Jul 202010:30 amRNSTotal Voting Rights
10th Jun 202011:06 amRNSDirector/PDMR Shareholding
1st Jun 20209:11 amRNSTotal Voting Rights
20th May 20201:57 pmRNSHolding(s) in Company
13th May 20202:06 pmRNSDirector/PDMR Shareholding
7th May 20201:04 pmRNSResult of AGM
7th May 20207:00 amRNSInterim Management Statement & Coronavirus update
1st May 202010:03 amRNSTotal Voting Rights
30th Apr 20204:48 pmRNSHolding(s) in Company
27th Apr 20205:27 pmRNSDisclosure of rights attached to equity shares
21st Apr 20201:07 pmRNSChange of Venue for the 2020 AGM
21st Apr 202012:30 pmRNSDirector Declaration
16th Apr 20204:26 pmRNSHolding(s) in Company
15th Apr 20202:20 pmRNSDirector/PDMR Shareholding
14th Apr 20204:42 pmRNSDirector/PDMR Shareholding
1st Apr 20209:56 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSCoronavirus update
26th Mar 20203:58 pmRNSHolding(s) in Company
18th Mar 20204:56 pmRNSDirector/PDMR Shareholding
17th Mar 20204:37 pmRNSDirector/PDMR Shareholding
12th Mar 202010:52 amRNSDirector/PDMR Shareholding
11th Mar 202012:18 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:10 pmRNSTotal Voting Rights
28th Feb 20207:00 amRNSPreliminary results, year ended 31 December 2019
12th Feb 20203:07 pmRNSDirector/PDMR Shareholding
3rd Feb 202010:55 amRNSTotal Voting Rights
15th Jan 202012:15 pmRNSDirector/PDMR Shareholding
13th Jan 20203:31 pmRNSHolding(s) in Company
3rd Jan 202011:54 amRNSBlock listing Interim Review
2nd Jan 20202:04 pmRNSTotal Voting Rights
11th Dec 20192:40 pmRNSDirector/PDMR Shareholding
2nd Dec 201910:20 amRNSTotal Voting Rights
27th Nov 20199:00 amRNSNon-executive director changes
21st Nov 20198:10 amRNSDirector/PDMR Shareholding
14th Nov 201910:04 amRNSDirector/PDMR Shareholding
7th Nov 20197:00 amRNSIMS and Strategy Review conclusions
1st Nov 201910:04 amRNSTotal Voting Rights
9th Oct 20192:07 pmRNSDirector/PDMR Shareholding
1st Oct 201910:17 amRNSTotal Voting Rights
23rd Sep 20197:00 amRNSCompletion of PBM acquisition
16th Sep 20193:51 pmRNSDirector/PDMR Shareholding
11th Sep 20191:08 pmRNSDirector/PDMR Shareholding
2nd Sep 201910:18 amRNSTotal Voting Rights
20th Aug 20197:00 amRNSProposed acquisition of PBM for $85m
14th Aug 20191:42 pmRNSDirector/PDMR Shareholding
12th Aug 20193:40 pmRNSNon-executive director change
1st Aug 20194:17 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.